Ellanse (PCL Dermal Filler)

Ellanse is a sterile, latex free, non-pyrogenic, totally bioreabsorbable, non-permanent implant whose principle component is synthetic Poly-E-Caprolacton (PCL) microspheres suspended in a carrier gel.

PCL is a well known totally bio-reabsorbable soft polymer that stimulate connective tissue regrowth.  Ellanse gives a longer lasting result than hyaluronic acid products and can be used once a patient is comfortable with the result from HA dermal fillers. In the first 4 weeks following a treatment the product injected gives the desired volumisation, thereafter the body starts to produce connective tissue such as collagen which gives long lasting results.

You should not receive an Ellanse treatment if any of the following applies: history of severe allergic reactions, acute skin inflammation, history of keloid scarring, if you are undergoing cortisone or steroid treatment, history of auto-immune conditions, if you have any permanent implants in the face, or if you are pregnant, breastfeeding or planning to conceive.

Products used are:

Screen Shot 2018-01-30 at 22.35.29.png
Screen Shot 2018-01-30 at 22.35.07.png


These usually resolve spontaneously within hours or days, but may persist for longer, are:

  • Pain or stinging sensation when the injection is performed
  • Localised swelling, redness and/or tenderness
  • Bleeding at the site of injection
  • Bruising; and occasionally bruising can be severe and persist for several weeks
  • Numbness or itching of the area following injection

Whilst it is not expected, it is possible that reactions described may persist for longer than expected and may inhibit your confidence to attend work or social events. You are advised to schedule treatment with this in mind, allowing time for common reactions to settle.



  • Infection
  • Inflammation that may occur within a few days or weeks-months following treatment
  • Skin discolouration that may occur within a few days or weeks-months following treatment
  • Allergic or sensitivity reaction, which may be local (redness, itching, rash at the site of treatment) or severe requiring hospital treatment.
  • Absess formation
  • Prolonged swelling that may occur early or after several weeks
  • Persistent lumps, nodules or papules
  • Acne like formations
  • A foreign body reaction known as Granuloma presenting as lumps or nodules
  • The blood supply to the skin may be interrupted by swelling or inadvertent injection into a vessel - causing pain, skin damage and possible scarring.
  • Though rare in the extreme, transient visual disturbance or permanent blindness has been reported following injectable cosmetic treatments.